Fellow Health, a startup based in San Leandro, California, just secured $24 million in a Series B funding round. This funding boosts their total to $48 million, which they plan to use to improve male reproductive health services.
Fellow Health focuses on mail-in semen analysis, offering privacy and convenience with clinical-grade testing. They have over 2,500 fertility and urology partners across the U.S. and aim to expand into employer-sponsored fertility benefits.
The recent funding comes from notable investors, including 5AM Ventures and Forest Road. Bill Burkoth from Forest Road stated, “Fellow Health is filling a crucial gap in male reproductive health.” They’ve already provided more than 50,000 test results this year, indicating strong demand for their services.
Understanding male fertility is critical. For instance, live sperm can survive in a woman’s body for several days but die quickly when outside. Fellow Health’s mail-in kits include a preservation solution to keep samples viable during transit. This is especially helpful for post-vasectomy testing, where both living and dead sperm are counted.
Fellow Health’s CEO, Brian Hogan, shared their growth aspirations, stating they expect over 40% revenue growth this year. However, they face increasing competition. Other companies, like Posterity Health and Dadi, are also making strides in the male fertility market. Posterity recently raised $13 million and is collaborating with the Mark Cuban Cost Plus Drug Company to enhance access to treatments.
As more attention is given to male reproductive health, customer interest is rising. Social media discussions reflect growing awareness and acceptance of these important topics. Fellow Health’s approach of making testing accessible and straightforward may help shift the narrative around male health and fertility.
For more detailed insights on the evolving landscape of male reproductive health, you can check trusted sources like the Mayo Clinic here.
Fellow Health is positioning itself to lead in what was once a neglected area of health, proving that innovation can thrive in even the most unexpected markets.
Source link
semen analysis, 5AM Ventures, Life Sciences Bill Burkoth, male fertility, Health